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Introduction
TNF receptor associated periodic syndrome (TRAPS) is an
autosomal dominant disease caused by gain-of-function
mutations in the TNF superfamily receptor 1A (TNFRSF1A)
gene encoding 55 kDa TNF receptor type I (TNFR1).
TRAPS is characterized by episodes of fever accompanied
by severe abdominal pain, arthralgia, myalgia, rash, chest
pain, enlarged glands and red, swollen eyes. Duration of the
attacks can range from few days to several weeks, with the
onset from early childhood to adulthood.
Objective
To identify the cause of fever in a 41 year old man who
suffered with symptoms of severe abdominal pain, head-
ache, arthralgia, myalgia, night sweats, generalised
erythema and unilateral non-painful cervical lymphade-
nopathy which started from early adolescence, but
became more severe after he recently returned from
working overseas. He had 10 and 12 attacks per year
each lasting almost exactly two weeks.
Methods
The patient underwent screening of the four genes:
MEFV (the gene associated with FMF); TNFRSF1A (the
gene associated with TRAPS) NLRP3 (the gene associated
with CAPS) and MVK (the gene associated with MKD).
DNA was extracted from whole blood, saliva, buccal
epithelial cells, hair root and from isolated monocytes,
T and B lymphocytes and neutrophils.
Result
A novel in-frame deletion of 24 nucleotides (c.255_278del)
in exon 3 of the TNFRSF1A gene was identified by PCR
and Sanger sequencing in DNA extracted from whole
blood, but the size of mutated nucleotide peaks on the
chromatogram were notably smaller than wild-type, rais-
ing the possibility of mosaicism. The latter was confirmed
by targeted sequencing, which established the frequency of
the mutant allele in the DNA isolated from whole blood
as 7.36% and the virtual absence of variant sequence in
purified epithelial cells (buccal swab), but substantial
representation of the mutation in T lymphocytes and neu-
trophils. Analysis of parental DNA showed only wild-type
TNFRSF1A gene sequence, corroborating that the deletion
identified in our patient had occurred de novo.
Conclusion
We report first mosaic patient with TRAPS caused by a
novel TNFRSF1A deletion of 24 nucleotides found in
7.36% of cells. The patient responded extremely well to
treatment with anakinra, including a complete remission
of symptoms and normalization in SAA and CRP.
The deletion of highly conserved residues, including
the F60 amino acid, which is crucial for proper protein
folding, is likely to introduce profound changes to the
function and three dimensional shape of the TNFR1
potentially impairing its folding and binding with TNF.
Authors’ details
1National Amyloidosis Centre, University College London, London, UK.
2Institute of Child Health, UCL, London, UK.
Published: 28 September 2015
doi:10.1186/1546-0096-13-S1-O60
Cite this article as: Rowczenio et al.: First case of somatic mosaicism in
TRAPS caused by a novel 24 nucleotides deletion in the TNFRSF1A
gene. Pediatric Rheumatology 2015 13(Suppl 1):O60.1National Amyloidosis Centre, University College London, London, UK
Full list of author information is available at the end of the article
Rowczenio et al. Pediatric Rheumatology 2015, 13(Suppl 1):O60
http://www.ped-rheum.com/content/13/S1/O60
© 2015 Rowczenio et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
